investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
Dennis Klinman
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Xuemei Zhong
In vivo study of a unique phagocytic L2pB1 B lymphocyte in diet induced obesity
All cancers but non-melanoma skin cancer
Yi Tang
Characterization and Engineering of Fungal Megasynthases
All cancers but non-melanoma skin cancer
Ronglai Shen
Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis
All cancers but non-melanoma skin cancer
Jairaj Acharya
Phospholipid and Sphingolipid Signaling in Drosophila
All cancers but non-melanoma skin cancer
Leonid S Metelitsa
Localization and Function of NKT Cells in Neuroblastoma
All cancers but non-melanoma skin cancer
Vineet KewalRamani
Cytoplasmic-Nuclear Trafficking of HIV-1
All cancers but non-melanoma skin cancer
Tina Yuan
A systematic dissection of oncogenic KRAS signaling for target identification and therapeutic development
All cancers but non-melanoma skin cancer
John Schiller
Preclinical Evaluation of Crucell's Ad26 and Ad35, in Intravaginal Vaccination in Mouse Models
All cancers but non-melanoma skin cancer
Dominique C Bergmann
Control of epidermal self-renewing populations by bHLH and MAPK regulatory system
All cancers but non-melanoma skin cancer